PMDA — authorised 23 March 2021
- Marketing authorisation holder: Recordati Rare Diseases Japan K.K.
- Status: approved
🇯🇵 Isturisa in Japan
PMDA authorised Isturisa on 23 March 2021
Marketing authorisation
Isturisa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Japan
Frequently asked questions
Is Isturisa approved in Japan?
Yes. PMDA authorised it on 23 March 2021.
Who is the marketing authorisation holder for Isturisa in Japan?
Recordati Rare Diseases Japan K.K. holds the Japanese marketing authorisation.